Cargando…
Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells
B-cell chronic lymphocytic leukemia (CLL) was believed to result from clonal accumulation of resting apoptosis-resistant malignant B lymphocytes. However, it became increasingly clear that CLL cells undergo, during their life, iterative cycles of re-activation and subsequent clonal expansion. Drugs...
Autores principales: | Bruno, Silvia, Ledda, Bernardetta, Tenca, Claudya, Ravera, Silvia, Orengo, Anna Maria, Mazzarello, Andrea Nicola, Pesenti, Elisa, Casciaro, Salvatore, Racchi, Omar, Ghiotto, Fabio, Marini, Cecilia, Sambuceti, Gianmario, DeCensi, Andrea, Fais, Franco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673187/ https://www.ncbi.nlm.nih.gov/pubmed/26265439 |
Ejemplares similares
-
Berberine affects mitochondrial activity and cell growth of leukemic cells from chronic lymphocytic leukemia patients
por: Ravera, Silvia, et al.
Publicado: (2020) -
Metformin and Cancer Glucose Metabolism: At the Bench or at the Bedside?
por: Marini, Cecilia, et al.
Publicado: (2021) -
Metformin Impairs Glucose Consumption and Survival in Calu-1 Cells by Direct Inhibition of Hexokinase-II
por: Salani, Barbara, et al.
Publicado: (2013) -
Two high-rate pentose-phosphate pathways in cancer cells
por: Cossu, Vanessa, et al.
Publicado: (2020) -
Old and New Facts and Speculations on the Role of the B Cell Receptor in the Origin of Chronic Lymphocytic Leukemia
por: Bagnara, Davide, et al.
Publicado: (2022)